drugset / Trial / NCT06514313
Clinical Trial of VIM With VIT in Children With Relapsed and Refractory Soft Tissue Sarcoma.
RandomizedParallel-groupOpen-labelTreatment
Summary
Explore the efficacy and safety of mitoxantrone liposome combined with irinotecan and vincristine (VIM) in the treatment of relapsed/refractory soft tissue sarcoma in children.
Timeline
- Start
- 2024-07-03
- Primary completion
- 2026-08-01
- Completion
- 2026-12-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Mitoxantrone | Small molecule | — | Intravenous |
| Comparator | Temozolomide | Small molecule | — | — |
| Comparator | Irinotecan | Small molecule | — | — |
| Comparator | Vincristine | Small molecule | — | — |